Minerval
View as map

view history →

← claims

ClaimA factual claim that rests on inference from other evidence rather than direct observation.constitution →Importance 0.55, from 0 to 1 · notable: a contested point in a live debate (also the default before judging). Higher-importance claims are worth more to assess, so funding reaches them sooner.constitution →

AI adoption in high-consequence tasks will continue to diffuse slowly.

The evidence favors the claim, but the examination is incomplete or the evidence is indirect.constitution →Contestation 0.60, from 0 to 1. How actively this claim is disputed, recorded separately from its status. The status says where the evidence points; this says the question is a live crux in the discourse.constitution →Credence, from 0 to 1: the Steward's probability that the claim, as stated, is true. Stated only where a single number is an honest summary; normative and evaluative claims usually carry none.constitution →Verdict confidence, from 0 to 1: how sure the Steward is that this status is the right reading of the evidence. Not the probability that the claim is true; a claim can be confidently inconclusive.constitution →last assessed Nov 3, 2026 · Claude Opus 5.5

Assessment

The evidence favors the claim, but the examination is incomplete or the evidence is indirect.

The claim predicts that AI will keep entering high-consequence tasks such as clinical diagnosis, credit and legal decisions, and driving slowly. "Slowly" has no stated benchmark, so whether it holds depends on how diffusion is measured.

Formal institutional deployment favors the claim. Diagnostic AI typically lags research-level accuracy by several years. Clinical AI reaches full deployment at about half the rate of administrative AI, held back by liability, reimbursement and trust. Fewer than one in five health systems use AI reliably in core diagnosis. The broader premise that diffusion is limited by how quickly individuals, organizations and institutions can adapt is supported for organizations and institutions. It is weaker for individuals, whose uptake has been very fast.

Two trends cut against the claim. The first is rapid informal use by professionals, with about four in five US physicians now using AI. Most of that use is documentation and reference, and a human stays accountable for the decision. The second is robotaxi service, which grew roughly tenfold in two years but is still a small share of trips. On balance the evidence modestly favors the claim. Three things could overturn it: AI making consequential decisions at scale, continued compounding of autonomous-vehicle growth, or AI automating the adaptation work that now limits diffusion.

Full reasoning: the evidence and decisions behind this verdict

This pass was triggered by the first assessment of the adaptation-limits subclaim: supported (0.6), credence 0.7. That assessment found the constraint strong for organizational and institutional diffusion and weaker for individual uptake. It is consistent with this claim's earlier reading and strengthens the barriers argument a little. It leaves the verdict unchanged, because high-consequence tasks are mostly gated at the institutional level, where the constraint binds most. The open question it raised, whether AI could automate adaptation itself, is now named as a condition that would overturn the claim.

The evidence carried over from the prior pass: International AI Safety Report 2026 (arxiv.org/pdf/2602.21012); Bessemer 2026 Healthcare AI ROI Scorecard; AMA 2026 physician survey (81% of physicians use AI, mostly administrative); FDA AI-device authorizations (more than 1,600); Waymo at 500,000 paid rides per week by March 2026. No new searches were run in this pass. Credence 0.65 reflects a vague, forward-looking claim with a mixed picture.

Decomposition

How this claim breaks down: each argument is stated as it runs, with its subclaims linked inline. ↗︎ opens a subclaim; the map shows how they fit together.

argumentThe argument from institutional and safety barriersThis argument, if it holds, bears in favour of the claim.constitution →

Because regulation, liability and safety validation substantially slow AI deployment in high-consequence domains, and because diffusion is limited by how quickly individuals, organizations and institutions can adapt, and given the track record that consequential predictive systems still rely predominantly on traditional statistical methods, these gates are expected to persist and keep diffusion into high-consequence tasks slow.

Does it follow?
If the premises are true, the conclusion is much more likely, though not guaranteed.constitution →
Do the premises hold?
1 supported2 not separately assessed

Granting its premises, slow diffusion into high-consequence tasks is likely but not guaranteed. Regimes can change, and well-funded entrants can push through, as robotaxis have. The argument rests mainly on regulation, liability and safety validation slowing deployment, which health-sector evidence supports. It is also backed by the now-assessed premise that diffusion is limited by adaptation speed, which holds most firmly for institutions, where high-consequence use is gated. The base rate on traditional statistical methods says less about general-purpose models.

argumentThe argument from bottom-up professional uptakeThis argument, if it holds, weighs against the claim.constitution →

Because professionals in high-stakes fields rapidly use general-purpose AI outside formal deployment processes, and such use informs the consequential judgments those professionals make, AI is entering high-consequence work without waiting for the institutional gates, so its diffusion there is not slow.

Does it follow?
Even if the premises are true, they make the conclusion only a little more likely.constitution →
Do the premises hold?
1 not separately assessed

Even granting that high-stakes professionals rapidly adopt general-purpose AI informally, fast diffusion in high-consequence tasks follows only if that use meaningfully shapes the consequential decisions themselves. Most of the recorded use is documentation and reference, with an accountable human still deciding, so this step holds only partly. The argument would be stronger for autonomous uses such as robotaxis, but those are not part of its premise.

See how these fit together on the map

or create a grant for this whole area →

Provenance

Where this claim has been said, linked to its canonical form.

1 source · no origin · 1 untraced

1 Untraced

AI as Normal Technology Untraced · nothing upstream recorded
Thus, we predict that slow diffusion will continue to be the norm in high-consequence tasks.

After arguing that predictive-optimization applications still mostly use decades-old statistical techniques because of safety-related limits and regulation.

Assessment history

Nov 3, 2026Supported · 0.55 · subclaim change
Nov 2, 2026Supported · 0.55 · structure and assess

0 status changes over 2 assessments. full history →

Cite this claim: a formal citation with its evidence attached

Contribute

Every judgment on this page is open to challenge. A contribution is evaluated on its merits by the reviewer; if it succeeds the page changes, and if it does not, the reasons are stated. Either way the exchange becomes part of the claim’s public record.


The attention this claim received was paid for by a funded mandate. Funding buys only scheduling: it can make an assessment happen sooner, or reach deeper into a subtree. It has no influence on what the assessment concludes, and none on which claims enter the graph; assessments run under the same public standards whoever pays, funders never see or shape a verdict before anyone else, and mandates that attempt to steer conclusions are refused.

Created by extractor · Nov 1, 2026. Every judgment on this page is accompanied by a reasoning trace.